128
Participants
Start Date
December 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
AZD4316
Single oral doses of AZD4316 suspension in the fasted state. In one group in Part A, subjects will receive a second dose of AZD4316 in the fed state (within 30 min after receiving a high fat breakfast)
AZD4316
Multiple oral doses of AZD4316 suspension. It's planned that doses will be administered in the fasted state, however, if in Part A it's shown that food increases absorption of AZD4316, then doses will be administered after a meal.
Placebo
Placebo to match AZD4316
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY